Synonyms: | |
Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | Parent |
UNII: | 4KM2BN5JHF |
InChI Key | UWFYSQMTEOIJJG-FDTZYFLXSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C24H29ClO4 |
Molecular Weight | 416.95 |
AlogP | 4.61 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 60.44 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 29.0 |
Primary Target | |
---|---|
Androgen receptor |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Nucleotide-like receptor (family A GPCR)
Adenosine receptor
|
- | 5-125 | - | 1-1 | - | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
- | 631-18000 | - | 14 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 103 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hot Flashes | 3 | D019584 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
Endometriosis | 3 | D004715 | ClinicalTrials |
Acne Vulgaris | 3 | D000152 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Polycystic Ovary Syndrome | 2 | D011085 | ClinicalTrials |
Menopause | 2 | D008593 | ClinicalTrials |
Hyperplasia | 0 | D006965 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 427-51-0 |
ChEBI | 50743 |
ChEMBL | CHEMBL139835 |
DrugBank | DB04839 |
DrugCentral | 766 |
EPA CompTox | DTXSID5020366 |
FDA SRS | 4KM2BN5JHF |
Guide to Pharmacology | 2865 |
PDB | CA4 |
PubChem | 9880 |
SureChEMBL | SCHEMBL5936 |
ZINC | ZINC000003814423 |